Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Tetrathiomolybdate in Patients With Wilson Disease
This study has been completed.
Study NCT00004339 Information provided by National Center for Research Resources (NCRR)
First Received: October 18, 1999 Last Updated: May 8, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Wilson Disease
Additional conditions recognized in this trial
Hepatolenticular Degeneration
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Digestive System Diseases
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Liver Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Metal Metabolism, Inborn Errors
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Interventions listed in this trial
tetrathiomolybdate
trientine
Additional drug interventions recognized in this trial
Molybdenum
Triethylenetetramine
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Chelating Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Trace Elements
Sponsors listed in this trial
National Center for Research Resources (NCRR)
University of Michigan
Back to top of Main Content
